ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0458

Predictive Models for Thromboembolic Events in Giant Cell Arteritis: A US Veterans Health Administration Population-Based Study

Despina Michailidou1, Tianyu Zhang2, Andreas Diamantopoulos3, Pavlos Stamatis4 and Bernard Ng5, 1Division of Rheumatology, University of Washington, Seattle, WA, 2Department of Biostatistics, University of Washington, Seattle, WA, 3Akershus University Hospital, Lørenskog, Norway, 4Department of Clinical Sciences Lund, Rheumatology, Lund University, Sweden, Larissa, Larisa, Greece, 5Rheumatology Section, VA Puget Sound Healthcare System, Seattle, WA

Meeting: ACR Convergence 2022

Keywords: Cardiovascular, Epidemiology, giant cell arteritis, glucocorticoids, prognostic factors

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 12, 2022

Title: Vasculitis – Non-ANCA-Associated and Related Disorders Poster I: Giant Cell Arteritis

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: Giant cell arteritis (GCA) is an independent risk factor for thromboembolic events. The purpose of our study was to identify prognostic factors for thromboembolic events in patients with GCA and develop quantitative predictive tools for pulmonary embolism (PE) and deep venous thrombosis (DVT).

Methods: In this retrospective analysis we included a total of 13,029 patients with GCA. We investigated potential predictors of PE and DVT by using univariate and multivariate Cox regression models. Nomograms were then constructed based on the results of these Cox models. We also assessed the accuracy and predictive ability of our models by using calibration curves and cross-validation concordance index.

Results: Age, inpatient status at the time of initial diagnosis of GCA, number of hospitalizations after diagnosis of GCA, duration of glucocorticoid therapy for at least 6 months, and 5 year average Charlson score prior to the diagnosis of GCA were all found to be predictive factors of thromboembolic events. Prognostic nomograms were then prepared based on these predictors with promising prognostic ability (Figures 1 and 2). The probability of surviving thromboembolic events over an observation period of 5 years was illustrated with survival plots, after stratifying patients based on predicted risk (Figure 3). The concordance index of the survival models for both PE and DVT was 0.64, indicating a good predictive ability.

Conclusion: Our suggested nomograms based on specific prognostic factors can accurately predict the 1-year probability of developing PE or DVT among patients with GCA.

Supporting image 1

Figure 1. Nomogram for predicting the 1-year probability of PE in patients with GCA. NumAdmissions, number of admissions; Outpt, outpatient; Inpt, inpatient

Supporting image 2

Figure 2. Nomogram for predicting the 1-year probability of DVT in patients with GCA. NumAdmissions, number of admissions; Outpt, outpatient; Inpt, inpatient

Supporting image 3

Figure 3. Kaplan-Meier plot for the time to PE (A) and DVT (B) from the time of diagnosis of GCA stratified by predicted risk (blue and red lines).


Disclosures: D. Michailidou, Chemocentryx, Pfizer US Pharmaceuticals Group; T. Zhang, None; A. Diamantopoulos, GE Royalties for lectures; P. Stamatis, None; B. Ng, None.

To cite this abstract in AMA style:

Michailidou D, Zhang T, Diamantopoulos A, Stamatis P, Ng B. Predictive Models for Thromboembolic Events in Giant Cell Arteritis: A US Veterans Health Administration Population-Based Study [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/predictive-models-for-thromboembolic-events-in-giant-cell-arteritis-a-us-veterans-health-administration-population-based-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/predictive-models-for-thromboembolic-events-in-giant-cell-arteritis-a-us-veterans-health-administration-population-based-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology